Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

An orofacial pain specialty: An asset or liability to dentistry and the public.

Cooper BC.

Cranio. 2019 Nov;37(6):344-346. doi: 10.1080/08869634.2019.1664813. No abstract available.

PMID:
31581939
2.

A New Device Improves Signs and Symptoms of TMD.

Cattaneo R, Pietropaoli D, Cooper BC, Capparè D, Ortu E, Monaco A.

Pain Res Manag. 2019 May 6;2019:5646143. doi: 10.1155/2019/5646143. eCollection 2019.

3.

Drs. Greene and Obrez's article inaccurate.

Cooper BC.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2015 Dec;120(6):776. doi: 10.1016/j.oooo.2015.07.039. Epub 2015 Sep 26. No abstract available.

PMID:
26548730
4.

An assessment of the usefulness of Kinesiograph as an aid in the diagnosis of TMD: a review of Manfredini et al.'s studies.

Cooper BC, Adib F.

Cranio. 2015 Jan;33(1):46-66. doi: 10.1179/2151090314Y.0000000010. Epub 2014 Jul 2. Review.

PMID:
25115950
5.

TMD diagnostics.

Cooper BC.

J Am Dent Assoc. 2013 Sep;144(9):980, 982. No abstract available.

PMID:
23989832
6.

More About TMD.

Cooper BC.

J Am Dent Assoc. 2012 Oct;143(10):1074-6; author reply 1076-80. No abstract available.

PMID:
23024304
7.

Temporomandibular disorders: A position paper of the International College of Cranio-Mandibular Orthopedics (ICCMO).

Cooper BC; International College of Cranio-Mandibular Orthopedics (ICCMO).

Cranio. 2011 Jul;29(3):237-44.

PMID:
22586834
8.
9.
11.

Effect of ovarian suppression with gonadotropin-releasing hormone agonist on glucose disposal and insulin secretion.

Toth MJ, Cooper BC, Pratley RE, Mari A, Matthews DE, Casson PR.

Am J Physiol Endocrinol Metab. 2008 Jun;294(6):E1035-45. doi: 10.1152/ajpendo.00789.2007. Epub 2008 Apr 15.

12.
13.
14.
15.

Effect of a daily supplement of soy protein on body composition and insulin secretion in postmenopausal women.

Sites CK, Cooper BC, Toth MJ, Gastaldelli A, Arabshahi A, Barnes S.

Fertil Steril. 2007 Dec;88(6):1609-17. Epub 2007 Apr 6.

16.

Perceived infertility-related stress correlates with in vitro fertilization outcome.

Cooper BC, Gerber JR, McGettrick AL, Johnson JV.

Fertil Steril. 2007 Sep;88(3):714-7. Epub 2007 Feb 20.

PMID:
17316631
17.

Insulin resistance with hormone replacement therapy: associations with markers of inflammation and adiposity.

Cooper BC, Burger NZ, Toth MJ, Cushman M, Sites CK.

Am J Obstet Gynecol. 2007 Feb;196(2):123.e1-7.

18.

Conservative treatment of placenta accreta.

Hatfield JL, Brumsted JR, Cooper BC.

J Minim Invasive Gynecol. 2006 Nov-Dec;13(6):510-3.

PMID:
17097571
19.

Testosterone replacement increases vasodilatory reserve in androgen-deficient female rats.

Cooper BC, Gokina NI, Osol G.

Fertil Steril. 2007 Feb;87(2):422-5. Epub 2006 Nov 1.

PMID:
17081525
20.

Asymptomatic lung carcinoma presenting with a large vulvar lesion.

Cooper BC, Buekers TE, Flynn CM, Sorosky JI, Buller RE.

J Low Genit Tract Dis. 2001 Jan;5(1):48-50.

PMID:
17043562
21.

More about TMD and SEMG.

Cooper BC.

J Am Dent Assoc. 2006 Oct;137(10):1366; author reply 1366, 1368. No abstract available.

PMID:
17012709
22.

Evidence against a role for ovarian hormones in the regulation of blood flow.

Cooper BC, Sites CK, Fairhurst PA, Toth MJ.

Fertil Steril. 2006 Aug;86(2):440-7. Epub 2006 Jun 9.

PMID:
16764868
23.
24.

Novel modification of the vertical rectus abdominis myocutaneous flap for neovagina creation.

Sood AK, Cooper BC, Sorosky JI, Ramirez PT, Levenback C.

Obstet Gynecol. 2005 Mar;105(3):514-8.

PMID:
15738017
25.

The effect of hormone replacement therapy on body composition, body fat distribution, and insulin sensitivity in menopausal women: a randomized, double-blind, placebo-controlled trial.

Sites CK, L'Hommedieu GD, Toth MJ, Brochu M, Cooper BC, Fairhurst PA.

J Clin Endocrinol Metab. 2005 May;90(5):2701-7. Epub 2005 Feb 1.

PMID:
15687338
26.

Pseudoaneurysm of the uterine artery requiring bilateral uterine artery embolization.

Cooper BC, Hocking-Brown M, Sorosky JI, Hansen WF.

J Perinatol. 2004 Sep;24(9):560-2.

PMID:
15329736
28.
29.

Presumed antepartum amniotic fluid embolism.

Kent KJ, Cooper BC, Thomas KW, Zlatnik FJ.

Obstet Gynecol. 2003 Sep;102(3):493-5.

PMID:
12962930
30.

Scleroderma and solvent exposure among women.

Garabrant DH, Lacey JV Jr, Laing TJ, Gillespie BW, Mayes MD, Cooper BC, Schottenfeld D.

Am J Epidemiol. 2003 Mar 15;157(6):493-500.

PMID:
12631538
31.

Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer.

Cooper BC, Ritchie JM, Broghammer CL, Coffin J, Sorosky JI, Buller RE, Hendrix MJ, Sood AK.

Clin Cancer Res. 2002 Oct;8(10):3193-7.

32.

Preoperative CA 125 levels: an independent prognostic factor for epithelial ovarian cancer.

Cooper BC, Sood AK, Davis CS, Ritchie JM, Sorosky JI, Anderson B, Buller RE.

Obstet Gynecol. 2002 Jul;100(1):59-64.

PMID:
12100804
33.

Potential risk factors for undifferentiated connective tissue disease among women: implanted medical devices.

Laing TJ, Schottenfeld D, Lacey JV Jr, Gillespie BW, Garabrant DH, Cooper BC, Heeringa SG, Alcser KH, Mayes MD.

Am J Epidemiol. 2001 Oct 1;154(7):610-7.

PMID:
11581094
34.

Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae.

Black PN, Blasi F, Jenkins CR, Scicchitano R, Mills GD, Rubinfeld AR, Ruffin RE, Mullins PR, Dangain J, Cooper BC, David DB, Allegra L.

Am J Respir Crit Care Med. 2001 Aug 15;164(4):536-41.

PMID:
11520711
35.

Serological evidence of infection with Chlamydia pneumoniae is related to the severity of asthma.

Black PN, Scicchitano R, Jenkins CR, Blasi F, Allegra L, Wlodarczyk J, Cooper BC.

Eur Respir J. 2000 Feb;15(2):254-9.

36.

Petroleum distillate solvents as risk factors for undifferentiated connective tissue disease (UCTD).

Lacey JV Jr, Garabrant DH, Laing TJ, Gillespie BW, Mayes MD, Cooper BC, Schottenfeld D.

Am J Epidemiol. 1999 Apr 15;149(8):761-70.

PMID:
10206626
37.

The role of bioelectronic instruments in the management of TMD.

Cooper BC.

Dent Today. 1998 Jul;17(7):92-7. No abstract available.

PMID:
9796465
38.

Not fit to print.

Cooper BC.

N Y State Dent J. 1997 May;63(5):10, 13-4. No abstract available.

PMID:
9188253
39.

Racial differences in scleroderma among women in Michigan.

Laing TJ, Gillespie BW, Toth MB, Mayes MD, Gallavan RH Jr, Burns CJ, Johanns JR, Cooper BC, Keroack BJ, Wasko MC, Lacey JV Jr, Schottenfeld D.

Arthritis Rheum. 1997 Apr;40(4):734-42.

40.

The role of bioelectronic instrumentation in the documentation and management of temporomandibular disorders.

Cooper BC.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997 Jan;83(1):91-100.

PMID:
9007931
41.

The role of bioelectronic instruments in documenting and managing temporomandibular disorders.

Cooper BC.

J Am Dent Assoc. 1996 Nov;127(11):1611-4. No abstract available.

PMID:
8952236
42.

The epidemiology of scleroderma among women: assessment of risk from exposure to silicone and silica.

Burns CJ, Laing TJ, Gillespie BW, Heeringa SG, Alcser KH, Mayes MD, Wasko MC, Cooper BC, Garabrant DH, Schottenfeld D.

J Rheumatol. 1996 Nov;23(11):1904-11.

PMID:
8923364
43.

Who represents the TMD practitioner?

Cooper BC.

Cranio. 1996 Oct;14(4):251-3. No abstract available.

PMID:
9110618
44.

The role of bioelectronic instruments in the management of TMD.

Cooper BC.

N Y State Dent J. 1995 Nov;61(9):48-53.

PMID:
8524518
46.

Roxithromycin 150 mg b.i.d. versus amoxycillin 500 mg/clavulanic acid 125 mg t.i.d. for the treatment of lower respiratory tract infections in general practice.

Karalus NC, Garrett JE, Lang SD, Leng RA, Kostalas GN, Cursons RT, Cooper BC, Ryan CJ.

Infection. 1995;23 Suppl 1:S15-20.

PMID:
7782110
47.

Cost effectiveness of roxithromycin versus cefaclor in Australia.

Scott WG, Cooper BC, Scott HM, Tilyard MW, Dovey SM.

Pharmacoeconomics. 1995 Jan;7(1):93-4. No abstract available.

PMID:
10155297
48.

Roxithromycin and lower respiratory tract infections.

Scott WG, Cooper BC, Scott HM, Karalus NC, Garrett J, Lang SD.

N Z Med J. 1994 May 25;107(978):208. No abstract available.

PMID:
7980759
49.

Tarnished gold standard.

Cooper BC.

N Y State Dent J. 1994 Mar;60(3):8-9. No abstract available.

PMID:
8170634
50.

High resolution epitope mapping of an anti-DNA autoantibody using model DNA ligands.

Swanson PC, Cooper BC, Glick GD.

J Immunol. 1994 Mar 1;152(5):2601-12.

PMID:
7510750

Supplemental Content

Loading ...
Support Center